Oncology Institute Inc (TOI) USD0.0001

Sell:$1.23Buy:$1.30$0.12 (10.53%)

Prices delayed by at least 15 minutes
Sell:$1.23
Buy:$1.30
Change:$0.12 (10.53%)
Prices delayed by at least 15 minutes
Sell:$1.23
Buy:$1.30
Change:$0.12 (10.53%)
Prices delayed by at least 15 minutes

Company Information

About this company

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Key people

Daniel Virnich
Chief Executive Officer, Director
Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Jeremy N. Castle
Chief Operating Officer
Jordan Mcinerney
Chief Development Officer
Yale Podnos
Chief Medical Officer
Richard A. Barasch
Independent Chairman of the Board
Brad Hively
Independent Vice Chairman of the Board
Karen M. Johnson
Independent Director
Mohit Kaushal
Independent Director
Gabriel Ling
Independent Director
Click to see more

Key facts

  • EPIC
    TOI
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • ISIN
    US68236X1000
  • Market cap
    $100.05m
  • Employees
    825
  • Shares in issue
    77.49m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.